<DOC>
	<DOCNO>NCT02319941</DOCNO>
	<brief_summary>The purpose study compare Low-Dose , Standard-Dose Ticagrelor Clopidogrel Inhibition Platelet Reactivity Patients Acute Coronary Syndromes</brief_summary>
	<brief_title>Comparison Low-Dose , Standard-Dose Ticagrelor Clopidogrel Inhibition Platelet Reactivity Patients With Acute Coronary Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>ST elevation non ST elevation acute coronary syndrome patient chest pain within 24 hour Known hypersensitivity clopidogrel ticagrelor aspirin Treatment anticoagulants Exposure thrombolytic agent within 24 hour prior randomization Use glycoprotein IIb IIIa inhibitor randomization History major hemorrhage ( intracranial , gastrointestinal , etc . ) clot disorder and/or bleed disorder Any history Severe renal hepatic dysfunction Hematologic disorder include Hemoglobin le 10 g/L platelet count le 80,000 cells/mm3 Cardiac shock , severe leave ventricular dysfunction LVEF le 30 % Sick sinus syndrome second degree av block without permanent pacemaker No concurrent cytochrome p450 3a inhibitor enhancer within 2 week Subject condition , opinion investigator , participation would best interest subject ( eg , drug alcohol abuse , mental illness ) could prevent , limit , confound protocolspecified assessment . Life expectancy le 6 month Pregnancy lactate Participation drug study previous 3 month Inability follow protocol comply followup requirement reason investigator feel would place patient increase risk</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Inhibition Platelet Reactivity</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>